Generic Name: margetuximab (MAR je TUX i mab)
Brand Name: Margenza
Medically reviewed by Philip Thornton, DipPharm. Last updated on Feb 5, 2021.
What is Margenza?
Margenza (margetuximab) is a human epidermal growth factor receptor (HER2) inhibitor that slows or stops cell growth.
Margenza injection is used in combination with other cancer drugs to treat breast cancer that has spread to other parts of the body (metastatic).
Margenza is given after at least two other cancer treatments did not work or have stopped working.
Margenza is used only if your cancer has a specific genetic marker (an abnormal "HER2/neu" gene). Your doctor will test you for this gene.
Margenza may cause heart problems. Call your doctor at once if you have symptoms such as: fast or pounding heartbeats, cough, shortness of breath, swelling, or rapid weight gain.
Margenza can cause harm to the unborn baby if used while pregnant. Effective contraception must be used during treatment and for 4 months following the last dose.
Before taking this medicine
Margenza may harm an unborn baby. Use effective birth control to prevent pregnancy, and tell your doctor if you become pregnant. Keep using birth control for at least 4 months after your last dose.
You may need to have a negative pregnancy test before starting this treatment.
It may not be safe to breastfeed while using Margenza, and for at least 4 months after your last dose. Ask your doctor about any risk.
Tell your doctor if you have ever had heart problems.
How is Margenza given?
Margenza is given as an infusion into a vein. A healthcare provider will give you this injection.
Margenza injection is usually given once every 3 weeks. Follow your doctor's dosing instructions very carefully.
Margenza injection must be given slowly, and the infusion can take 30 minutes to 2 hours to complete.
Your heart function may need to be checked using an electrocardiograph (sometimes called an EKG) or ultrasound. Your cancer treatments may be delayed or permanently discontinued based on the results.
Usual Adult Dose for Breast Cancer:
15 mg/kg IV every 3 weeks
-Infuse initial dose over 120 minutes and subsequent doses over 30 minutes.
-This drug may be administered immediately after the completion of chemotherapy.
-Continue treatment until disease progression or unacceptable toxicity.
-All therapeutic proteins, including this drug, have the potential to produce an immune response.
Use: In combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, at least one of which was for metastatic disease
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment for your injection.
What happens if I overdose?
Since Margenza is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.
What should I avoid while receiving Margenza?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
Margenza side effects
Get emergency medical help if you have signs of an allergic reaction to Margenza: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Some side effects may occur during the injection. Tell your caregiver if you feel dizzy, tired, nauseated, light-headed, itchy, feverish, chilled, or have a headache, joint pain, cough fast heartbeats, trouble breathing, or swelling in your face.
Call your doctor at once if you have:
blisters or ulcers in your mouth, red or swollen gums, trouble swallowing;
heart problems - fast or pounding heartbeats, cough, feeling light-headed or short of breath, swelling in your face or lower legs, rapid weight gain (more than 5 pounds in 1 day);
hand-foot syndrome - pain, blisters, bleeding, or severe rash on the palms of your hands or the soles of your feet; or
low white blood cell counts - fever, mouth sores, skin sores, sore throat, cough, trouble breathing.
Common Margenza side effects may include:
feeling weak or tired;
cough, trouble breathing;
pain, numbness, tingling, or burning pain in your arms or legs;
hand-foot syndrome; or
muscle or joint pain.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What other drugs will affect Margenza?
Margetuximab can have long-lasting effects on your body. For at least 4 months after your last dose of Margenza, you should not be treated with certain other cancer drugs. Tell each of your doctors about your treatment with this medicine.
Other drugs may interact with margetuximab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
More about Margenza (margetuximab)
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- Drug class: HER2 inhibitors
- FDA Approval History
Related treatment guides
- Your doctor pharmacist can provide more information about Margenza.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Margenza only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2021 Cerner Multum, Inc. Version: 1.01.